Understanding barriers and facilitators to lifestyle management in people with polycystic ovary syndrome: A mixed method systematic review

Documenti analoghi

• Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline
  di: Alyse Goldberg, et al.
  Pubblicazione: (2024)
• Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges
  di: Saeede Saadati, et al.
  Pubblicazione: (2025)
• Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome
  di: Francisco J. Ponce‐Díaz, et al.
  Pubblicazione: (2025)
• Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis
  di: Jing Ling, et al.
  Pubblicazione: (2025)
• Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity—A systematic review, meta‐analysis, and meta‐regression
  di: Suhaniya N. S. Samarasinghe, et al.
  Pubblicazione: (2024)